IMARC Group, a leading market research company, has recently releases report titled “Dengue Testing Market Report by Test Type (ELISA-based Tests, RT-PCR based Tests, Dengue IgG/IgM Rapid Test, and Others), End User (Hospitals, Diagnostic Centers, and Others), and Region 2024-2032”, Offers a comprehensive analysis of the industry, which comprises insights on the global dengue testing market.
How Big is the Dengue Testing Market?
The global dengue testing market size reached US$ 584.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 879.0 Million by 2032, exhibiting a growth rate (CAGR) of 4.6% during 2024-2032.
Industry Overview of Dengue Testing
Dengue testing is utilized to diagnose dengue fever, which is a virus spread by mosquitoes. It is primarily available in two types, including molecular tests like polymerase chain reaction (PCR) and serological tests like enzyme-linked immunosorbent assay (ELISA) identify antibodies generated in response to the infection. It facilitates early detection, allowing for prompt medical attention and lowering the possibility of consequences like dengue hemorrhagic fever. It offers a precise diagnosis that avoids mishandling, such as giving medications for a viral infection when they are not needed. It contributes to the larger goal of disease management and eradication by being a useful tool for epidemiological research and vaccine development.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/dengue-testing-market/requestsample
What are the growth prospects and trends in the dengue testing industry?
At present, the rising occurrence of dengue cases around the world due to lack of effective vector control represents one of the crucial factors impelling the market growth. Additionally, increasing advancements in diagnostic technologies, such as the development of rapid testing kits and point-of-care tests (POCT), are facilitating quicker and more accurate diagnoses.
Besides this, the growing efforts to educate the public about the seriousness of dengue fever are offering a favorable market outlook. In addition, the increasing collaboration between public and private entities for research and development (R&D) of better testing methods is supporting the market growth. Furthermore, the growing focus on combating vector-borne diseases, including dengue, by international bodies like the World Health Organization (WHO) is positively influencing the market. Apart from this, rising improvements in supply chain management are ensuring the easy availability of diagnostic kits and tools.
Additionally, the increasing integration of data analytics in healthcare to predict dengue outbreaks is contributing to the market growth. Moreover, the growing availability of medical supplies, including test kits, through online platforms is making it easier for healthcare providers to procure them.
Leading Companies Operating in the Global Dengue Testing Industry:
- Abbott Laboratories
- Abnova Corporation
- CerTest Biotec S.L.
- DiaSorin S.p.A.
- F. Hoffmann-La Roche AG
- InBios International Inc.
- NovaTec Immundiagnostica GmbH
- OriGene Technologies Inc.
- PerkinElmer Inc.
- Quest Diagnostics Incorporated
- Thermo Fisher Scientific Inc.
Dengue Testing Market Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Test Type:
- ELISA-based Tests
- RT-PCR based Tests
- Dengue IgG/IgM Rapid Test
- Others
Breakup by End User:
- Hospitals
- Diagnostic Centers
- Others
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
